Searching for early warning signs: can a simple blood test predict severe COVID-19 in vulnerable transplant patients?
NCT ID NCT04369456
Summary
This study aimed to find early signs in the blood that could predict if a kidney transplant patient's COVID-19 infection would get worse. Researchers followed 52 recently infected kidney transplant patients who had mild-to-moderate symptoms, as these patients are at higher risk. They tested blood samples to see if levels of a specific inflammation marker (IL-6) could forecast serious outcomes like needing intensive care or death.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONAVIRUS INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
APHM
Marseille, 13000, France
-
APHP
Paris, 75000, France
-
Lyon Univerity Hospital
Lyon, 69000, France
-
Montpellier University Hospital
Montpellier, 34000, France
-
Saint Etienne University Hospital
Saint-Etienne, 42000, France
-
Strasbourg Univeristy Hospital
Strasbourg, 67000, France
-
University Nice Hospital
Nice, 06000, France
Conditions
Explore the condition pages connected to this study.